002880 卫光生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.27610.65411.99911.3436.511
总资产报酬率 ROA (%)0.8377.0008.2128.0205.132
投入资产回报率 ROIC (%)0.9397.9239.2578.8095.564

边际利润分析
销售毛利率 (%)37.73839.36441.87841.32036.068
营业利润率 (%)17.72522.42224.65323.58720.686
息税前利润/营业总收入 (%)19.56923.96926.35324.60120.338
净利润/营业总收入 (%)13.86819.40521.10720.74818.147

收益指标分析
经营活动净收益/利润总额(%)104.376102.457102.13590.60780.089
价值变动净收益/利润总额(%)3.8551.994-2.9173.02813.605
营业外收支净额/利润总额(%)-0.383-0.3490.038-0.755-0.619

偿债能力分析
流动比率 (X)2.3622.3693.6134.1494.932
速动比率 (X)0.8321.1291.7371.6192.296
资产负债率 (%)32.48734.62331.94028.89127.493
带息债务/全部投入资本 (%)23.22224.22021.53918.18321.319
股东权益/带息债务 (%)319.044301.650352.116432.487359.395
股东权益/负债合计 (%)205.085186.297209.970242.351259.953
利息保障倍数 (X)10.23714.74715.59120.649-92.217

营运能力分析
应收账款周转天数 (天)140.59961.99228.16527.16762.315
存货周转天数 (天)597.360392.830377.450374.036432.981